Recent Company News

• 12:34 AM ET Jul 31, 2025
  

  Otsuka Holdings reports H1 net income attributable ¥173.53B vs guidance JPY173.00B (¥7358.0000, +122)

• 10:49 PM ET Jul 28, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 07:34 PM ET Jul 28, 2025
  

  Otsuka Holdings guides H1 net income attributable ¥173.00B vs prior guidance ¥147.00B (¥7010.0000, 0)

• 04:57 AM ET Jul 25, 2025
  

  Otsuka Holdings to sell 15.7% stake in MicroPort Scientific; terms undisclosed (HK$10.94, 0.00)

• 07:06 AM ET Jul 21, 2025
  

  Ionis Pharmaceuticals announces journal publication of data from Phase 3 OASISplus prospective switch study of donidalorsen in patients with HAE ($41.76, 0.00)

• 05:48 PM ET Jul 18, 2025
  

  Otsuka and Lundbeck issue statement on FDA advisory committee meeting results for sNDA of Rexulti in combo with setraline for PTSD (DKK 33.86, 0.00)

• 03:41 PM ET Jul 18, 2025
  

  FDA panel votes against the efficacy data of Rexulti in combo with setraline for PTSD (¥6581.0000, 0)

• 08:43 AM ET Jul 17, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:09 PM ET Jul 17, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market